The Partnership for Personalized Medicine places Arizona institutions in the center of exciting new developments in the future of healthcare.
Personalized Medicine Initiative
Since 2002, Phoenix set out to establish itself in the rapidly changing, highly competitive field of bioscience.
A new, independent Translational Genomics Research Institute (TGen) took root through a public-private partnership.Arizona State University launched the ambitious Biodesign Institute to solve some of the world’s most urgent health and environmental problems.
In January 2006, Piper Trust announced a commitment to invest $50 million in the newly emerging field of personalized medicine. This investment had the potential for catalytic change in medical research by strengthening local institutions, creating a network of collaborative research endeavors and attracting high profile researchers.
A breakthrough occurred in October 2007 when Dr. Lee Hartwell, Nobel laureate and director of Fred Hutchinson Cancer Research Center, Seattle, became interested in the potential Phoenix had to support a major personalized medicine collaboration with TGen and ASU Biodesign to create the Partnership for Personalized Medicine.
Since then, a major lung cancer initiative with the Duchy of Luxembourg has come on line and Dr. Hartwell and Dr. Josh LaBaer, a renowned proteomics researcher from Harvard University joined the Biodesign Institute.
FOR MORE INFORMATION ABOUT BIOSCIENCE IN ARIZONA:  
|